Avanos Medical, Inc. announced that Michael Greiner, senior vice president and chief financial officer, will present and participate in a fireside chat at the UBS 2022 Global Healthcare Conference on Monday, May 23 at approximately 1:15 p.m., ET.
ALPHARETTA, Ga., May 17, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present and participate in a fireside chat at the UBS 2022 Global Healthcare Conference on Monday, May 23 at approximately 1:15 p.m., ET.
A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.
About Avanos Medical:
Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients’ quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today’s most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries. For more information, visit www.avanos.com and follow Avanos Medical on Twitter (@AvanosMedical), LinkedIn and Facebook.
View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-ubs-2022-global-healthcare-conference-301549251.html
SOURCE Avanos Medical, Inc.
Company Codes: NYSE:AVNS
